Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_assertion type Assertion NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_head.
- NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_assertion description "[The expression of PHD1, PHD2 and PHD3 together with HIF-1? and the HIF-inducible genes vascular endothelial cell growth factor (VEGF) and carbonic anhydrase IX were assessed by immunohistochemistry using a tissue microarray approach in 211 patients with T2-4 N0-1 breast cancer enrolled in a randomised trial comparing single-agent epirubicin versus epirubicin and tamoxifen as the primary systemic treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_provenance.
- NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_assertion evidence source_evidence_literature NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_provenance.
- NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_assertion SIO_000772 21291529 NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_provenance.
- NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_assertion wasDerivedFrom befree-2016 NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_provenance.
- NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_assertion wasGeneratedBy ECO_0000203 NP869999.RAwzP12YXFiWbXEJNxQfKJdMuc_lBOJF4J_8Mgc1v0qVM130_provenance.